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Abstract We previously reported that the D39N mutant of Drosophila lcohol dehydrogenase (ADH), in which Asp-39 is replaced with asparagine, 
has a 60-fold increase in athnity for NADP’ and a lJ-fold increase in k,, compared to wild-type ADH [Chen et al. (1991) Eur. J. B&hem. 202, 
263-267) and proposed that this part of ADH is close to the r-phosphate on the ribose moiety of NADP+. Here we report the effect of replacing 
Ala-46 with an argine residue, an A46R mutant, on binding of NADP+ to ADH and its catalytic efficiency with the NADP’ cofactor, and a modeling 
of the three-diiensional structure of the NAD’-binding region of ADH. The A46R mutant has a 2.5-fold lower Xm(lpp)nADP+ anda 3-fold higher 
/c_~ with NADP’ compared to wild-type ADH, binding of NAD’ to the mutant was unchanged and km, with NAD’ was lowered by about 30%. 
For the A46R mutant, the ratio of k-,/G of NAD+ to NADP+ is 85, over ten-fold lower than that for wild-type ADH. Our model of the 3D structure 
of the NAD’-binding region of ADH shows that Ala46 is over 10 A from the ribose moiety of NAD+, which would suggest hat there is little 
interaction between this residue and NAD+ and explain why its mutation to arginine has little effect on NAD+ binding. However. the positive charge 
at residue 46 can neutralize some of the coulombic repulsion between Asp-39 and the r-phosphate on the ribose moiety of NADP+, which would 
increase its a%nity for the A46R mutant. We also constructed a double mutant, D39N/A46R mutant, which we find has a 30-fold lower K&lppjN~Dp+ 
and 8-fold higher k,, with NADP’ as a cofactor compared to wild-type ADH; binding of NAD+ to this double mutant was lowered by 5-fold and 
k_* was increased by 1.5-fold. As a result, k_&,, for the double mutant was the same for NAD+ and NADP+. The principle ffect of the two mutations 
in ADH is to alter its at%ity for the nucleotide cofactor; k,, decreases lightly in A46R with NAD+ and remains unchanged or increases in the other 
mutants. 
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1. Irltrodnctlon 
Drosophila alcohol dehydrogenase (ADH) has a preference 
for secondary alcohols [l-7] and does not require a metal ion 
for catalysis, in contrast to the yeast and horse liver alcohol 
dedhydrogenases. Drosophila ADH shares a common ancestor 
[8-121 with human 1 I&hydroxysteroid dehydrogenase, 17/I- 
hydroxysteroid dehydrogenase, and 15-hydroxyprostaglandin 
dehydrogenase; nzymes that regulate the concentration of glu- 
cocorticoids, estrogens, and prostaglandins, respectively, in hu- 
mans and are thus of importance in various endocrine-related 
diseases [13-151. 
The mechanism of catalysis of ADH and its homologs is only 
beginning to be understood. The importance of the N-terminus 
of ADH in binding the nucleotide cofactor was first shown 
when Thatcher sequenced an inactive ADH mutant and found 
that Gly-15 was replaced by aspartic acid [16]. Site-specific 
mutagenesis tudies with cloned Adh also indicate that the N- 
terminus is important in binding of the nucleotide cofactor 
[5,171. Other studies indicate that Tyr-153 and Lys-157 are 
important in hydride ion transfer [18,19]. The latter is in agree- 
ment with similar studies on 1 l/%hydroxysteroid ehydroge- 
nase [20] and NAD’-dependent 15-hydroxyprostaglandin de- 
hydrogenase [21]. 
Among the questions that are still partially answered for 
ADH and its homologs are the determinants for specificity for 
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NAD’ and NADP’. Some progress has been made from anal- 
ysis of crystal structures of two ADH homologs: Streptomyces 
hydrogenans 20j?-hydroxysteroid ehydrogenase [22] cocrys- 
tallized with NAD’, and rat dihydropteridine reductase [23,24] 
co-crystallized with NADH. Despite their low sequence similar- 
ity, their tertiary stuctures have many similarities: both show 
that the amino-terminus consists of a /.%x/I fold, a structure that 
comprises the binding domain for the AMP moiety of the 
nucleotide cofactor in a wide range of non-homologous ox- 
idoreductases [25-281. The orientation, however, of the nucleo- 
tide cofactor differs in the two tertiary structures, with the 
orientation of NADH in dihydropteridine teductase similar to 
that in other oxidoreductases [25-281. Gur previous studies with 
ADH mutants [5,17j suggested that the 2’-OH of the ribose 
moiety of AMP may be close to Drosophila ALMS’s Asp39 at 
the C-terminus of the second /?-strand in the /?a/3 fold. This 
orientation is similar to that found for dihydropteridine reduc- 
tase and for human 15-hydroxyprostaglandin dehydrogenase 
[29]. The latter conclusion is based on a photoaffinity labeling 
study. 
Like those studying glutathione reductase [28] and yeast alco- 
hol dehydrogenase [30], we are attempting to engineer an ADH 
molecule that has a cofactor specificity different from that of 
the wild-type enzyme. Scrutton et al. [28] found that a combina- 
tion of adding a negatively charged residue and removing pos- 
itively charged residues close to the C-terminus of the second 
B-strand improved the catalytic efficiency of glutathione reduc- 
tase with NADH by a factor of -70 while lowering the catalytic 
efficiency with NADPH by a factor of -250. Fan et al. [30] found 
that replacing an aspartate residue with a glycine residue at the 
C-terminus of the second /?-strand in yeast alcohol dehydroge- 
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nase yield an enzyme with similar catalytic efficiency for NAD’ 
and NADP’. 
These reports suggest hat adding one or more positively 
charged residues near the C-terminus of the second B-strand on 
ADH could increase the affinity for NADP”. We have adopted 
this approach in constructing mutants in which Ala-46 in wild- 
type ADH and in the D39N mutant is replaced with an argin- 
ine, and determined the effect on binding of, and catalytic 
efficiency with, NADP’ and NAD’. As reported here, a posi- 
tive charge at position 46 increases the affinity for NADP’ 
compared to wild-type ADH. A D39N/A46R mutant has the 
same k,JK,,, for NADP’ and NAD’. We also constructed a 3D 
model of ADH using 20j3-hydroxysteroid dehydrogenase and 
dihydropteridine reductase as templates. This aaproach has 
been successfully used by Krook et al. to model the 3D struc- 
ture of human NADP’-dependent 15hydroxyprostaglandin 
dehydrogenase [3 l] and human NADP’-dependent 15-hy- 
droxyprostaglandin dehydrogenase (carbonyl reductase) [32] 
using 20jLhydroxysteroid ehydrogenase as a template, despite 
the extensive sequence divergence among these enzymes, giving 
us confidence in this approach to model the structure of ADH. 
Our findings for ADH may be useful for studies with its steroid 
and prostaglanding dehydrogenase homologs, in which the de- 
terminants for cofactor specificity have not been studied. 
2. Materials and methods 
2.1. Materials 
The vectors, bacterial strains and phage used for expression and 
mutagenesis of Drosophila ADH were described previously by Chen et 
al. [15,19]. Altered Site System was purchased from Promega Corp. All 
restriction endonucleases, DNA ligase, DNA kinase, and Klenow frag- 
ment of E. coli DNA polymerase I were ordered from Bethesda Re- 
search Laboratories, New England Biolabs Inc., or Promega Corp. 
Sequenase kits were obtained from United States Biochemicals Corp. 
2.2. Expression andpurification of the wild-type and mutated 
Drosophila ADH 
A vector containing the full-length ADH cDNA in E. coli strain 
M5219, which carries the ~1857 thermosensitive-repressor gene, was 
used to express wild-type and mutated ADH [5,19]. The Altered Sites 
System (Promega) and Kunkel’s method were used to produce point 
mutations [33]. The expression of wild-type ADH and its mutants in 
E. co/i cells was verified by Western blot analysis and ADH enzyme 
activity, as described previously [5,19]. 
2.3. Determination of kinetic uarameters 
ADH activity was determined spectrophotometrically at 340 nm in 
100 mM glycine-NaOH buffer @H 9.8) at 25’C. The concentration of 
NAD’ and alcohol for the determination of the kinetic coefficients were 
specified as follows: NAD’ and NADP+ 0.02-2 mM, and propan-2-01 
l-100 mM. Kmc~ppj was calculated from the initial-rate data measured 
at a constant concentration of NAD+ or NADP’ using the Enzhtter 
program. 
2.4. 30 modeling of ADH 
We used the homology program (Biosym, 1994) to model the ADH 
structure using as a template the reported tertiary structures of 
S. hydrogenans 20/?-hydroxysteroid dehydrogenase [22] and rat dihy- 
dropteridine reductase [23,24]. The NAD’ structure was obtained from 
the Brookhaven Protein Database. The ADH structure with NAD’ was 
calculated by extensive nergy minimization. The backbone of ADH 
was constrained uring minimization of 2,000 iterations. 
3. Results 
The codon substitutions for A46R, and the double mutants 
D39NlA46R and D39WA46R were confirmed by dideoxy 
DNA sequencing. All of the mutants could be expressed in an 
E. coli host. The D39R/A46R mutant has no activity, although 
it can be detected by Western analysis. Both A46R and the 
double mutant D39N/A46R are enzymatically active and were 
purified to homogeneity as verified by SDS-PAGE (data not 
shown). 
3.1. Kinetic analysis of wild-type ADH and mutants 
Table 1 summarizes the results of the analysis of wild-type 
ADH, A46R, D39N/A46R, and D39N. Replacing Ala-46 by 
arginine lowers the K,,, for NADP’ by 2.5 fold and increases 
k,, by about 2.5 fold; thus, k_JK,,, is 6.5 fold higher than that 
of the wild-type ADH. In the A46R mutant, the Z& for NAD’ 
decreases lightly, while k,,, decreases by 30%; thus k-,/K, is 
about 60% of the wild-type ADH. 
The double mutation, D39N/A46R, lowers the Km of 
NADP+ by 30-fold and increases k,,, &fold compared to wild- 
type ADH. Compared to D39N mutant, the double mutant has 
a K, for NADP’ that is 2 fold higher, while k,, is about 20% 
lower. In D39NIA46R the catalytic efficiency, k,JK,,,, with 
NADP’ is 250 fold higher than that of wild-type ADH and 40% 
of D39N. 
The affinity of NAD’ for the double mutant decreased by 
3.5-fold compared to the D39N mutant, while kcat was un- 
changed; k,,lK,,, was 27% of that of wild-type and the D39N 
mutant. As a result, the D39NIA46R mutant has a similar 
k-,/K,,, for NADP’ and NAD’. 
Fig. 1 shows a model of part of the region in ADH that binds 
NAD’. Residues 13-18, which are part of the first turn in the 
j?c@ structure, form a glycine-rich hydrophobic pocket that 
allows close approach of the adenosine moiety. The model is 
Table 1 
Ku (ai,pj and k,, values for wild-type ADH*, D39N*, A46R and D39NIA46R 
Substrates Enzymes &VP) k,.&,c.~j 
(mM) (s-’ mM-‘) 
MutantAVT 
(ratio of kcatK,(appJ 
WT/mutant 
(ratio of kuK,,c~ppj 
NAD+/NADP+) 
NAD+ Wild-type 0.048 + 0.001 10.2 213 1 925 
A46R 0.057 + 0.003 7.3 127 0.60 84.5 
D39N 0.073 f 0.002 15.3 210 1 1.55 
D39NlA46R 0.260 f 0.03 15.0 58 0.27 1 
NADP’ Wild-type 3.09 + 0.70 0.715 0.230 1 
A46R 1.27 f 0.10 1.9 1.5 6.5 
D39N 0.050 2 0.003 6.80 136 590 
D39NlA46R 0.100 + 0.003 5.7 58 250 
*Data are from [5]. 
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Fig. 1. A model of the interaction of Drosophila alcohol dehydrogenase with NAD+. Drosophila ADH was modeled using 20fl-hydroxysteroid 
dehydrogenase [22] and diiydroptexidine r ductase. [23,24] as templates. Asp-39 and Ala-46, which have been mutated in this study, are shown. A 
ribbon shows Val-13 through Gly-18, which are part of thep-strand, turn. a-helix that are part of the canonical&B fold that binds NAD+. Tyr-153, 
Lys-157, and Thr-186 are also shown. Tyr-153 is the proposed catalytic residue. The positively charge Lys-157 is proposed to lower the pk: of tyrosine 
[19]; lysine’s interaction with the ribose moiety may orient NAD+ for pro-S hydride transfer [24]. The interaction of Thr-186 with the carboxamide 
group may stabilize the orientation of the cofactor with respect to the substrate and catalytic residue(s). 
consistent with previous investigations of the effects on ADH 
acitivity of mutations in Gly-15. Mutation to alanine reduces 
ADH activity by 30% [17], presumably due to alanine’s side 
chain interfering with adenosine binding; more disruptive mu- 
tations, in which either valine [17] or aspartic acid [16] replace 
Gly-15, lead to an inactive mutant. 
fold, while km,/& for NAD’ is unchanged. Thus, k,,lK,,, for 
NAD’ is 1.5 fold higher than for NADP’. 
The modeled structure reveals that Asp-39 and Ala-46 are 
distant from adenosine. Nevertheless, Asp-39 and Arg-46 are 
sufficiently close to have coulombic interactions with a 2’-phos- 
phate on NADP’. Fig. 1 also shows Tyr-153 and Lys-157, 
which are thought to be in the catalytic site [l&19], and Thr- 
186, which, unexpectedly, is close to the carboxamide moiety 
of NAD’. 
4. Discussion 
The modeled tertiary structure of ADH shown in Fig. 1 can 
clarify the basis for the above results and the other findings 
reported here. The position of Asp-39 shown in Fig. 1 indicates 
that there would be a strong coulombic repulsion between the 
2’-phosphate on NADP+ ribose and Asp-39 that would lower 
the affinity of NADP’ for wild-type ADH. On the other hand, 
Asp-39 is far enough from NAD’ so that the coulombic inter- 
action with adenine is not a major contributor to binding en- 
ergy of NAD+. Thus, replacing Asp-39 with asparagine does 
not appreciably change the affinity of NAD’ for ADH because 
of the similar size of the side chain. Evidently, the negative 
charge on Asp-39 is not essential for NAD’ binding to ADH 
or the enzyme’s active conformation. It may be that a role of 
Asp-39 is to prevent NADP’ binding to ADH. 
Wild-type ADH has a marked preference for NAD+ over The 3D model predicts that the binding pocket can accom- 
NADP+; k,,,/K,,, is 925-fold higher for NAD+ than for NADP’ modate the phosphate of NADP’ and that adding one or more 
[5]. We found that the negative charge of Asp-39 is an impor- positive charges to a nearby part of ADH will improve NADP’ 
tant influence on cofactor specificity [5]. Indeed, a D39N mu- binding. The A46R mutation of ADH confirms this prediction. 
tant of ADH, in which Asp-39 is replaced with asparagine, has The A46R mutant has a 6.5-fold increase in k,,,l&, with 
a 60 fold higher affinity and a 9.5 fold higher km, for NADP’ NADP’ compared to wild-type ADH, and a 40% lower kc&&, 
compared to the wild-type ADH; binding of NAD’ has a 35% with NAD’. The ratio of k,tlx, of NAD’ to NADP’ is 85, over 
lower affinity and k,, increases by 1.5 fold. The net effect of tenfold lower than that for wild-type ADH. There are two 
the D39N mutation is that k,,lx, for NADP+ increases by 590 contributions to the stabilization of NADP’ binding to ADH 
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due to the positive charge from the added Arg-46. First, it 
shields the 2’-phosphate on NADP” from the coulombic repul- 
sion of the carboxylate of Asp-39; that is, it compensates for 
the repulsion between Asp-39 and NADP’. The second is 
arginine’s coulombic attraction towards the Y-phosphate 
group on NADP’. 
Replacement of Asp-39 by asparagine accomplishes the first 
part. As a result, adding an A46R mutation to the D39N mu- 
tant does not have a dramatic effect on NADP+ binding. The 
D39N/A46R mutant has an equivalent &d& with either 
NADP’ or NAD+ as cofactors because k,JK,,, decreases 57% 
for NADP’ and 72% for NAD’ compared to D39N. 
The importance of the conformation of thepa@ fold in cofac- 
tor binding is well established. This part of ADH is higly con- 
served in other set-alcohol dehydrogenases [lO-12,34,35]. The 
loss of activity in the D39R/A46R mutant is likely to be due 
to the effect of adding two strong positively charged residues 
on ADH conformation, which is not compensated for by cou- 
lombic attraction to NADP’. 
Although we have focused on interaction of the N-terminal 
part of ADH and NAD’, the molecular model shows that parts 
of the C-terminal domain of ADH are close to NAD+. In 
particular, Qr-153, Lys-157, and Thr-186 interact with either 
nicotinamide or its ribose. Tyr-153 is proposed to be the cata- 
lytically active residue [4,18,19]; Lys-157 is proposed to lower 
the pK, of tyrosine to facilitate catalysis at neutral pH [19]. 
Another role for Lys-157 has come from analysis of the tertiary 
structure of dihydropteridine reductase [24]. Varughese et al. 
[24] proposed that the int raction of the holologous Lys- 150 on 
rat dihydropteridine reductase with the 2’-hydroxy group on 
the nicotinamide ribose could be important in orienting NAD’ 
for pro-S hydride transfer. This appears also to be true for 
ADH. 
An unexpected finding is the interaction of Thr-186 with the 
carboxamide substitutent of the nicotinamide group, which is 
similar to that reported by Varughese t al. [24] for Asn-186 of 
rat dihydropteridine reductase. This was surprising because 
Thr-186 is not a well-conserved residue in the set-alcohol 
dedydrogenase superfamily and would not be expected to be 
functionally important. Indeed, Thr-186 is in one of the most 
divergent segments, which is thought to be due to its impor- 
tance in substrate specificity [10,11,34,36] and the fact that the 
substrate structures are diverse. The interaction of Thr-186 
with NAD’ may be important in stabilizing the orientation of 
the cofactor with the substrate and catalytic residue(s) in ADH 
and explain why this part of ADH and its homologs is impor- 
tant in substrate specificity. 
Oxidation of alcohols by ADH proceeds by an ordered reac- 
tion [3,4,37] in which the binding of NAD’ induces a conforma- 
tional change in ADH that promotes substrate binding and 
catalysis. Fig. 1 suggests that the interactions between NAD’ 
and Tyr-153, Lys-157, and Thr-186 are important in stabilizing 
the conformation that allows the substrate to interact with the 
nicotinamide group and Tyr-153 for hydride transfer [19]. 
Among the ADH homologs, only dihydropteridine reductase 
has been studied regarding cofactor specificity. Grimshaw et al. 
[38] found that replacing Asp-37 with isoleucine on dihydrop- 
teridine reductase reduced the affinity of both NADH and 
NADPH. However, the release of NADPH was slower and of 
NADH faster in the mutant. 
Recently, Hohn et al. [39] presented evidence that E. coli 
UDP-galactose-4-epimerase has structural similarity to 208- 
hydroxyprostaglandin dehydrogenase and dihydropteridine 
reductase, two homologs of ADH. The structure of UDP-ga- 
lactase-4-epimerase [40] shows NAD’ oriented as reported for 
dihydropteridine reductase. UDP-4-galactose-epimerase is 
homologous to animal and viral 3&hydroxysteroid ehydroge- 
nases, Nocardia cholesterol dehydrogenase, and plant dihy- 
droflavonol reductases [4]. This expands the relevance of infor- 
mation about the residues important in catalysis by ADH. 
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